Dr. Dyan Hes Joins eMed Population Health as Chief Medical Officer

eMed Population Health Welcomes Dr. Dyan Hes

In a significant move toward enhancing population health management, eMed Population Health, Inc. has officially appointed Dr. Dyan Hes as their new Chief Medical Officer. This strategic decision, announced on September 30, 2025, is set to fortify the company's commitment to advancing health outcomes in preemptive care management. With over 25 years of experience in obesity medicine and pediatrics, Dr. Hes is poised to be a transformative force in this ambitious journey.

A Leader in Pediatric and Obesity Medicine

Dr. Hes is a board-certified pediatrician and a Diplomate of the American Board of Obesity Medicine (ABOM). Her leadership at eMed will revolve around guiding clinical, product, and technology teams to implement evidence-based care models that cater to a wide array of patient populations. A key aspect of her role will focus on optimizing GLP-1 therapies scaling them effectively across various demographics while ensuring cost-effectiveness for employers and insurers.

CEO Linda Yaccarino expressed excitement about Dr. Hes joining the leadership team, highlighting the impact of her extensive background in obesity medicine. "Her award-winning work will greatly accelerate eMed's evolution, reshaping what employee health benefits and public health programs can achieve," Yaccarino stated. This partnership is viewed as pivotal in driving real change in the healthcare landscape, particularly in preemptive care management.

The Vision Ahead

Dr. Hes is set to play a crucial role in substantial health advancements, focusing on adherence, retention, and clinical outcomes management for employers and payers. "We are at a pivotal moment in preemptive care management. eMed's transformational approach is at the forefront of driving what's possible for public health and medicine. We’re working to shape a healthier future for all we serve," Dr. Hes emphasized.

Beyond her executive role, Dr. Hes is well-known for her extensive contributions to the area of innovative weight loss treatments, particularly the use of GLP-1 agonists. As the founder and medical director of Highline Modern Medicine, a concierge practice based in New York City, she has dedicated her career to improving health outcomes for her patients in New York City, the Hamptons, and South Florida.

Before her current position, Dr. Hes was also recognized as the medical director of Gramercy Pediatrics, LLC in New York City. Her experience as a Director of the ABOM for eight years showcases her dedication and expertise. Moreover, her role as a medical correspondent for various media outlets like CBS and Fox News further solidifies her influence in the field.

eMed’s Innovative Approach

eMed is transforming the landscape of population health management with a revolutionary digital-first platform. This platform integrates at-home diagnostics, proctor-led screenings, physician-directed prescriptions, and ongoing adherence support. By combining these elements, eMed is establishing new benchmarks for employee health benefits and public health initiatives worldwide. The platform's adoption is growing rapidly among employers and payers globally, signifying a robust shift towards proactive health care solutions.

By expanding its provider network and enhancing data intelligence and behavioral health capabilities, eMed is laying the groundwork for measurable outcomes in healthcare and sustaining impact across large populations. The introduction of Dr. Hes comes at a critical time, enabling eMed to further its mission of redefining what effective population health management looks like.

Conclusion

In conclusion, the appointment of Dr. Dyan Hes as Chief Medical Officer at eMed Population Health marks a vital step forward in the realm of healthcare innovation. With her unparalleled expertise, Dr. Hes is set to lead eMed into a new era of health management, one that prioritizes evidence-based interventions and collaborative partnerships in driving improved health outcomes across diverse patient cohorts. As eMed continues to redefine population health, the fusion of her vision and the company’s mission promises a healthier future for many.